We are live on !
Find out more
Aberdeen Group Portfolio holdings
AUM
$71.2B
Turnover
9.3%
1-Year Est. Return
41.74%
This Fund
S&P 500
This Quarter Est. Return
+11.68%
1 Year Est. Return
+41.74%
3 Year Est. Return
+120.47%
5 Year Est. Return
+149.18%
10 Year Est. Return
–
AUM
$51B
AUM Growth
+$4.88B
(+11%)
Cap. Flow
+$834M
Cap. Flow % of AUM
Cap. Flow %
1.63%
Top 10 Holdings %
Top 10 Hldgs %
25.68%
Holding
986
New
26
Increased
432
Reduced
416
Closed
39
Avg Time Held
4.6
years
Top 10 Avg Time Held
3.2
years
Top 20 Avg Time Held
2.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kaspi.kz JSC
KSPI
|
+$260M |
| 2 |
Microsoft
MSFT
|
+$71.2M |
| 3 |
Cardinal Health
CAH
|
+$61.4M |
| 4 |
Clorox
CLX
|
+$47.7M |
| 5 |
Accenture
ACN
|
+$46.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sociedad Química y Minera de Chile
SQM
|
+$63.6M |
| 2 |
Splunk Inc
SPLK
|
+$56.2M |
| 3 |
L3Harris
LHX
|
+$46.8M |
| 4 |
Crown Holdings
CCK
|
+$43M |
| 5 |
Fomento Económico Mexicano
FMX
|
+$38.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.39% |
| 2 | Healthcare | 17.34% |
| 3 | Financials | 11.02% |
| 4 | Consumer Discretionary | 9.2% |
| 5 | Industrials | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
651
Federal Realty Investment Trust
FRT
$9.24B
| $5.6M | 0.01% |
54,808
+6,793
| +14% | +$687K |
2017 Q3
26 quarters
|
|
652
MGM Resorts International
MGM
$7.2B
| $5.57M | 0.01% |
117,888
-8,484
| -7% | -$371K |
2017 Q3
26 quarters
|
|
653
Hudson Pacific Properties
HPP
$559M
| $5.56M | 0.01% |
123,195
+366
| +0.3% | +$19.3K |
2017 Q3
26 quarters
|
|
654
TransUnion
TRU
$14.2B
| $5.54M | 0.01% |
69,370
+980
| +1% | +$71.8K |
2018 Q2
23 quarters
|
|
655
Revvity
RVTY
$17B
| $5.5M | 0.01% |
52,408
-201
| -0.4% | -$21.4K |
2017 Q3
26 quarters
|
|
656
DELISTED
WestRock Company
WRK
| $5.49M | 0.01% |
111,034
-920
| -0.8% | -$40.2K |
2017 Q3
26 quarters
|
|
657
DELISTED
89bio
ETNB
| $5.48M | 0.01% |
470,387
+256,195
| +120% | +$2.84M |
2023 Q4
1 quarter
|
|
658
Americold
COLD
$3.95B
| $5.42M | 0.01% |
217,456
-371,745
| -63% | -$10.2M |
2019 Q1
20 quarters
|
|
659
New Fortress Energy
NFE
$23.7M
| $5.26M | 0.01% |
3,441
-269
| -7% | -$442K |
2021 Q3
10 quarters
|
|
660
Alliant Energy
LNT
$17.7B
| $5.25M | 0.01% |
104,251
+574
| +0.6% | +$28.2K |
2017 Q3
26 quarters
|
|
661
Burlington
BURL
$16.5B
| $5.24M | 0.01% |
22,584
+334
| +2% | +$68.2K |
2017 Q3
26 quarters
|
|
662
FMC
FMC
$880M
| $5.23M | 0.01% |
82,050
-259,918
| -76% | -$15.2M |
2017 Q3
26 quarters
|
|
663
Procept Biorobotics
PRCT
$1.01B
| $5.17M | 0.01% |
104,707
-1,293
| -1% | -$61.5K |
2022 Q4
5 quarters
|
|
664
DELISTED
Juniper Networks
JNPR
| $5.16M | 0.01% |
139,349
-31,160
| -18% | -$1.14M |
2017 Q3
26 quarters
|
|
665
Ardelyx
ARDX
$798M
| $5.12M | 0.01% |
700,865
-132,749
| -16% | -$1.14M |
2023 Q4
1 quarter
|
|
666
DELISTED
Akero Therapeutics
AKRO
| $5.03M | 0.01% |
199,237
+127,695
| +178% | +$3.07M |
2023 Q4
1 quarter
|
|
667
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $5M | 0.01% |
552,572
| – | – |
2023 Q4
1 quarter
|
|
668
Eastman Chemical
EMN
$7.13B
| $4.98M | 0.01% |
49,728
| – | – |
2017 Q3
26 quarters
|
|
669
SS&C Technologies
SSNC
$19.7B
| $4.9M | 0.01% |
76,130
+1,087
| +1% | +$67.5K |
2018 Q2
23 quarters
|
|
670
Vodafone
VOD
$37.3B
| $4.85M | 0.01% |
544,900
-1,383,500
| -72% | -$12M |
2019 Q4
17 quarters
|
|
671
Match Group
MTCH
$9.9B
| $4.83M | 0.01% |
133,002
-688
| -0.5% | -$24.9K |
2019 Q4
17 quarters
|
|
672
Fidelity National Financial
FNF
$10.7B
| $4.82M | 0.01% |
90,688
+1,314
| +1% | +$66.2K |
2017 Q3
26 quarters
|
|
673
Bath & Body Works
BBWI
$4.06B
| $4.81M | 0.01% |
96,207
-139
| -0.1% | -$6.24K |
2017 Q3
26 quarters
|
|
674
F5
FFIV
$25B
| $4.75M | 0.01% |
25,080
-1,496
| -6% | -$276K |
2017 Q3
26 quarters
|
|
675
DELISTED
Crinetics Pharmaceuticals
CRNX
| $4.74M | 0.01% |
101,196
| – | – |
2023 Q4
1 quarter
|
|
Similar funds
Aberdeen Group's Q1 2024 Portfolio in Review
As of Q1 2024, Aberdeen Group held 986 positions worth $51B, up 11% from $46.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Aberdeen Group's Q1 2024 filing shows 26 new, 432 increased, 416 reduced and 39 closed positions. Its largest new stake was Kaspi.kz JSC: 2,541,596 shares worth $327M. The largest sale was Sociedad Química y Minera de Chile, an estimated $63.6M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
- Aberdeen Group's largest Q1 2024 buy was Kaspi.kz JSC: 2,541,596 shares worth $327M.
- Aberdeen Group added most to Microsoft in Q1 2024, an estimated $71.2M increase.
- Aberdeen Group's biggest Q1 2024 reduction was Sociedad Química y Minera de Chile, cutting an estimated $63.6M.
- Aberdeen Group fully exited Splunk Inc in Q1 2024, selling an estimated $56.2M.
- Aberdeen Group's ten largest holdings make up 26% of its $51B portfolio in Q1 2024.
- Aberdeen Group opened 26 new positions and closed 39 in Q1 2024.
- Aberdeen Group's portfolio value rose 11% quarter-over-quarter to $51B.
Based on Aberdeen Group's 13F filing for Q1 2024, filed 9 May 2024.